Description

Listing of 1,55,10,000 equity shares of Integrated Proteins Ltd issued on preferential basis pursuant to warrant conversion, effective December 18, 2025.

Summary

BSE has announced the listing of 1,55,10,000 new equity shares of Integrated Proteins Ltd (Scrip Code: 519606) effective from December 18, 2025. These shares were issued at Rs. 11.25 per share (face value Rs. 10 plus premium of Rs. 1.25) to Non-Promoters on a preferential basis pursuant to conversion of warrants. The allotment date was August 7, 2025.

Key Points

  • Company: Integrated Proteins Ltd
  • Scrip Code: 519606
  • ISIN: INE177M01013
  • Number of Shares: 1,55,10,000 equity shares
  • Face Value: Rs. 10 per share
  • Issue Price: Rs. 11.25 per share (including premium of Rs. 1.25)
  • Allottees: Non-Promoters
  • Basis: Preferential allotment pursuant to warrant conversion
  • Trading Commencement: December 18, 2025 (Thursday)
  • Distinctive Numbers: 3203601 to 18713600
  • Ranking: Pari-passu with existing equity shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification following SEBI preferential allotment guidelines.

Compliance Requirements

  • Trading members are informed to note the listing of these new securities
  • All 15,510,000 shares (Dist. Nos. 3203601 to 18713600) are subject to lock-in until June 30, 2026
  • Securities will trade under the existing scrip code 519606

Important Dates

  • Allotment Date: August 7, 2025
  • Listing and Trading Commencement: December 18, 2025
  • Lock-in Expiry: June 30, 2026

Impact Assessment

This is a company-specific listing action with limited market-wide impact. The preferential allotment increases the equity base of Integrated Proteins Ltd by 15.51 million shares. The lock-in period until June 30, 2026 ensures these shares cannot be sold immediately, providing stability. Trading members need to be aware of the increased share capital and lock-in restrictions for compliance purposes. The shares rank equally with existing equity shares in terms of rights and entitlements.

Impact Justification

Routine listing of new equity shares from warrant conversion for a single company. Standard corporate action with minimal market-wide impact.